5-bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine
- $474 - $2164
- Product name: 5-bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine
- CAS: 1638763-37-7
- MF: C7H5BrClN3
- MW: 246.49
- EINECS:
- MDL Number:MFCD27987407
- Synonyms:5-bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine;7H-Pyrrolo[2,3-d]pyrimidine, 5-bromo-2-chloro-7-methyl-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0620690
- Product description5-BROMO-2-CHLORO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE 95.00%
- Packaging5MG
- Price$498.49
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM270755
- Product description5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 95%+
- Packaging1g
- Price$773
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM270755
- Product description5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 95%+
- Packaging5g
- Price$2164
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11242086
- Product description5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 97%
- Packaging1g
- Price$474
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0620690 | 5-BROMO-2-CHLORO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE 95.00% | 5MG | $498.49 | 2021-12-16 | Buy |
Chemenu | CM270755 | 5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 95%+ | 1g | $773 | 2021-12-16 | Buy |
Chemenu | CM270755 | 5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 95%+ | 5g | $2164 | 2021-12-16 | Buy |
Crysdot | CD11242086 | 5-Bromo-2-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine 97% | 1g | $474 | 2021-12-16 | Buy |
Properties
Density :1.90±0.1 g/cm3(Predicted)
pka :2.45±0.30(Predicted)
pka :2.45±0.30(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|